Active trials

 

 

 

 

 

Active

The YELLOWSTONE Program is a series of Phase 3 clinical studies for people with moderately to severely active Crohn’s disease. These studies will evaluate the safety and effectiveness of an oral investigational study drug (ozanimod) which is taken once daily. Ozanimod is not a biologic,...

Read more
Start date:
2022-03-01 00:00:00

Is there a better way to optimise disease control for patients with ulcerative colitis? A new study aims to find out

Achieving and maintaining effective control of ulcerative colitis is the goal of treatment, but, as all patients know, it can be a challenge.  Current...

Read more
Start date:
2020-09-01 00:00:00